GSK's cancer drug Jemperli gets file acceptance from US FDA
GSK said on Tuesday that the U.S. Food and Drug Administration had granted file acceptance for its cancer drug, Jemperli, when combined with chemotherapy to treat adult patients with certain types of endometrial cancer.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.